Sirolimus-eluting stents for chronic total coronary occlusions: a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of chronic total coronary occlusions (PRISON II)

Trial Profile

Sirolimus-eluting stents for chronic total coronary occlusions: a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of chronic total coronary occlusions (PRISON II)

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Aug 2012

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms PRISON-II
  • Most Recent Events

    • 29 Aug 2012 Five-year angiographic results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
    • 01 Apr 2008 Results presented at ACC in 2008
    • 26 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top